Bertrand Ducrey
Algemeen Directeur bij Debiopharm International SA
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Thierry B. Mauvernay | M | - |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 23 jaar |
| Vanessa Currat | F | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Alexandre Maret | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 19 jaar |
| Manuela Perraudin | F | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Angela Zubel | F | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Frédéric Lévy | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Pierre Jullian | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 6 jaar |
| Nicolas Favre | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Jean-Maurice Dumonts | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 26 jaar |
| David Luc Deperthes | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 12 jaar |
| Thomas Gibbs | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Peggy Lipp | F | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Thomas Paulsen | M | 59 |
University of Lausanne
| 8 jaar |
| Bertrand Sager | M | 58 |
University of Lausanne
| 3 jaar |
| David Arcauz | M | - |
University of Lausanne
| 5 jaar |
| José François Sierdo | M | 61 |
University of Lausanne
| 4 jaar |
| Pierre-Dominique Schupp | M | 64 |
University of Lausanne
| 3 jaar |
| Ziping Liu | M | - |
University of Lausanne
| 3 jaar |
| Isabelle Romy | M | 59 |
University of Lausanne
| 3 jaar |
| Guy Joseph della Valle | M | 75 |
University of Lausanne
| 3 jaar |
| Beat Stocker | M | - |
University of Lausanne
| 2 jaar |
| Kathia Blauth | F | 52 |
University of Lausanne
| 4 jaar |
| Jean-Jacques Henchoz | M | 60 |
University of Lausanne
| 4 jaar |
| Liang Qiao | M | 62 |
University of Lausanne
| 3 jaar |
| Claudio Nessi | M | 56 |
University of Lausanne
| 4 jaar |
| Jay W. Schnyder | M | - |
University of Lausanne
| 2 jaar |
| Roger H. Hartmann | M | 66 |
University of Lausanne
| 5 jaar |
| Pietro Scalfaro | M | - |
University of Lausanne
| 4 jaar |
| Daniel Crausaz | M | 67 |
University of Lausanne
| 2 jaar |
| Yves Bonzon | M | 59 |
University of Lausanne
| 4 jaar |
| Yuan Wei Chen | M | 61 |
University of Lausanne
| 4 jaar |
| Patrick Conrad | M | - |
University of Lausanne
| 4 jaar |
| Thomas Steinmann | M | 63 |
University of Lausanne
| 3 jaar |
| Philippe Wiesel | M | - |
University of Lausanne
| 3 jaar |
| Oliver M. Bartholet | M | 58 |
University of Lausanne
| 3 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Zwitserland | 35 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Bertrand Ducrey
- Persoonlijk netwerk
